Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
Condition(s):Melanoma (Skin)Last Updated:November 19, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Melanoma (Skin)Last Updated:November 19, 2019Completed
Condition(s):Congenital Heart DiseaseLast Updated:April 8, 2021Unknown status
Condition(s):Respiratory Distress Syndrome in Premature InfantLast Updated:March 10, 2023Not yet recruiting
Condition(s):Depression; Suicidal IdeationLast Updated:July 15, 2022Completed
Condition(s):Osteosarcoma; Osteosarcoma RecurrentLast Updated:September 21, 2023Recruiting
Condition(s):Streptococcal PharyngitisLast Updated:March 15, 2024Recruiting
Condition(s):Food Allergy in ChildrenLast Updated:November 8, 2021Completed
Condition(s):Acute Pyelonephritis(APN)Last Updated:December 11, 2013Unknown status
Condition(s):Muscular Dystrophy, DuchenneLast Updated:September 3, 2015Unknown status
Condition(s):Epilepsy; Epilepsy in Children; Epilepsy; Seizure; Disease; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Epileptic SyndromesLast Updated:December 26, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.